Recro Pharma, Inc. (REPH)

[protagonist12]

They are hemorrhaging cash(i.e. secondary already in the works), are far behind on their trials and funding this deal through a 14% per-annum bridge loan despite having not achieved revenues to date. This is just a case of low float/irrational exuberance. I like co. but will wait it out until it gets back to 3s. And it will happen as long as they continue to fund operations with toxic financing.